RNS System

FDA-approved implantable responsive neurostimulation system for focal epilepsy. Continuously monitors and responds to abnormal brain activity.

Yes. RNS System is independently verified in real-world operation on the DEPLOY registry, confirmed at named deployment sites with primary sources: not a concept, render, or demo-only.

RNS System is made by NeuroPace, based in Mountain View, California, USA.

3 verified deployments of RNS System are on the DEPLOY registry, including at United States (comprehensive epilepsy centers), Los Angeles, California, USA, United States (comprehensive epilepsy centers nationwide).

RNS System is in commercial deployment and is sold to operators; contact the manufacturer to buy, and see the pricing section for any recorded price.

On the DEPLOY registry, comparable biometric robots to RNS System include Blackrock Neuroport Array, BrainQ Non-Invasive BCI, Neko Body Scan, Amazfit (Balance / Active / T-Rex / Helio).

RNS System and Blackrock Neuroport Array (Blackrock Neurotech · 5 deployments) are both biometric robots on the DEPLOY registry. RNS System has 3 verified deployments on record. Compare both records for specs, safety, deployments, and verified-vs-claimed autonomy.

On DEPLOY's intelligence score, which blends verified deployments, safety, adoption, media, and IP signals, RNS System ranks in roughly the top 30% of biometric models tracked by the registry.

RNS System is at the commercial stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Commercial stage means production-grade deployments are operating at named customer sites.

RNS System has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.